Stop codon mutations in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population

被引:36
|
作者
Yamazaki, Hiroshi [1 ]
Fujita, Haruka
Gunji, Takaaki
Zhang, Jun
Kamataki, Tetsuya
Cashman, John R.
Shimizu, Makiko
机构
[1] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo 1948543, Japan
[2] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan
[3] Human Biomol Res Inst, San Diego, CA 92121 USA
关键词
flavin-containing monooxygenase; fish-like odor syndrome; trimethylamine; truncated FMO3; Japanese; trimethylaminuria;
D O I
10.1016/j.ymgme.2006.08.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The reduced capacity of flavin-containing monooxygenase 3 (FMO3) to N-oxidize trimethylamine (TMA) is believed to cause a metabolic disorder. The aim of this study was to investigate the inter-individual variations of FMO3. Genomic DNA of case subjects that showed only 10-20% of FMO3 metabolic capacity among self-reported trimethylaminuria Japanese volunteers was sequenced. Functional analysis of recombinant FMO3 proteins was also performed. One homozygote for a novel single nucleotide substitution causing a stop codon at Arg500 was observed. The biological parents of this Proband A were heterozygous and showed > 90% TMA N-oxygenation metabolic capacity. Another Proband B had the Arg500Stop and Cys197Stop codons. The TMA N-oxygenation metabolic capacities of the father and brother of this Proband B were apparently observed by possessing Arg205Cys mutant that coded for decreased TMA N-oxygenase. Recombinant Arg500Stop FMO3 cDNA expressed in Escherichia coli membranes and a series of highly purified truncation mutants at different positions of the C-terminus of FMO3 showed no detectable functional activity toward typical FMO3 substrates. The results suggest that individuals homozygous for either of the nonsense mutations, Arg500Stop and/or Cys197Stop alleles, in the FMO3 gene can possess abnormal TMA N-oxygenation. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:58 / 63
页数:6
相关论文
共 50 条
  • [21] Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3)
    Allerston, Charles K.
    Shimizu, Makiko
    Fujieda, Masaki
    Shephard, Elizabeth A.
    Yamazaki, Hiroshi
    Phillips, Ian R.
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (10): : 827 - 839
  • [22] POSTNATAL EXPRESSION AND TISSUE DISTRIBUTION OF FLAVIN-CONTAINING MONOOXYGENASE 3 (FMO3)
    Xu, Zhen
    Yan, Bingfang
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S83 - S83
  • [23] Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway
    El-Serafi, Ibrahim
    Terelius, Ylva
    Abedi-Valugerdi, Manuchehr
    Naughton, Sean
    Saghafian, Maryam
    Moshfegh, Ali
    Mattsson, Jonas
    Potacova, Zuzana
    Hassan, Moustapha
    PLOS ONE, 2017, 12 (11):
  • [24] Phenotyping of flavin-containing monooxygenase using caffeine metabolism and genotyping of FMO3 gene in a Korean population
    Park, CS
    Chung, WG
    Kang, JH
    Roh, HK
    Lee, KH
    Cha, YN
    PHARMACOGENETICS, 1999, 9 (02): : 155 - 164
  • [25] Flavin-containing Monooxygenase (FMO3) Links the Gut and Fibrosis in Systemic Sclerosis
    Verma, Priyanka
    Yalavarthi, Bharath
    Ho, Karen
    Muhammad, Lutfiyya
    Kim, Seokjo
    Gudjonsson, Johann
    Schugar, Rebecca C.
    Brown, Mark
    Li, Xinmin
    Hazen, Stanley L.
    Bhattacharyya, Swati
    Varga, John
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1874 - 1876
  • [26] Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FMO3) gene in patients with fish-odour syndrome
    Dolphin, CT
    Janmohamed, A
    Smith, RL
    Shephard, EA
    Phillips, IR
    PHARMACOGENETICS, 2000, 10 (09): : 799 - 807
  • [27] Further survey of genetic variants of flavin-containing monooxygenase 3 (FMO3) in Japanese subjects found in an updated database of genome resources and identified by phenotyping for trimethylaminuria
    Shimizu, Makiko
    Hirose, Nagisa
    Kato, Mao
    Sango, Haruna
    Uenuma, Yumi
    Makiguchi, Miaki
    Hishinuma, Eiji
    Saito, Sakae
    Hiratsuka, Masahiro
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2022, 46
  • [28] Survey of variants of human flavin-containing monooxygenase 3 (FMO3) and their drug oxidation activities
    Yamazaki, Hiroshi
    Shimizu, Makiko
    BIOCHEMICAL PHARMACOLOGY, 2013, 85 (11) : 1588 - 1593
  • [29] Flavin-containing monooxygenase 3 (FMO3): genetic variants and their consequences for drug metabolism and disease
    Phillips, Ian R.
    Shephard, Elizabeth A.
    XENOBIOTICA, 2020, 50 (01) : 19 - 33
  • [30] Genetic variants of flavin-containing monooxygenase 3 (FMO3) derived from Japanese subjects with the trimethylaminuria phenotype and whole-genome sequence data from a large Japanese database
    Shimizu, Makiko
    Yoda, Hiromi
    Nakakuki, Komei
    Saso, Aoi
    Saito, Iria
    Hishinuma, Eiji
    Saito, Sakae
    Hiratsuka, Masahiro
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (05) : 334 - 339